Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Apr;116(1):174-80.
doi: 10.1046/j.1365-2249.1999.00864.x.

Up-regulation of intercellular adhesion molecule-1 (ICAM-1), endothelial leucocyte adhesion molecule-1 (ELAM-1) and class II MHC molecules on pulmonary artery endothelial cells by antibodies against U1-ribonucleoprotein

Affiliations

Up-regulation of intercellular adhesion molecule-1 (ICAM-1), endothelial leucocyte adhesion molecule-1 (ELAM-1) and class II MHC molecules on pulmonary artery endothelial cells by antibodies against U1-ribonucleoprotein

M Okawa-Takatsuji et al. Clin Exp Immunol. 1999 Apr.

Abstract

In order to elucidate the pathogenic role(s) of autoantibodies in connective tissue disease (CTD), we examined whether autoantibodies against U1-ribonucleoprotein (RNP) and double-stranded (ds) DNA can up-regulate ICAM-1, ELAM-1 and class I and II MHC molecule expression on pulmonary artery endothelial cells (HPAEC). ICAM-1, ELAM-1 and class II MHC molecule expression on HPAEC cultured in the presence of anti-U1-RNP-containing and anti-dsDNA-containing IgG from CTD patients was up-regulated significantly in comparison with that on HPAEC cultured with IgG from normal healthy volunteers. Affinity chromatographic enrichment and depletion of the anti-U1-RNP antibody content of anti-U1-RNP-containing IgG confirmed that the anti-U1-RNP antibody did up-regulate ICAM-1, ELAM-1 and class II MHC molecule expression. The finding that an IgG F(ab')2-purified anti-U1-RNP antibody also up-regulated expression of these molecules may indicate that mechanisms other than Fc receptor-mediated stimulation are involved. These in vitro findings suggest that autoantibodies against U1-RNP and dsDNA play important roles in the immunopathological processes leading to the proliferative pulmonary arterial vasculopathy observed in CTD patients with pulmonary hypertension by up-regulating adhesion and class II MHC molecule expression on endothelial cells.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Expression of adhesion (ICAM-1 and ELAM-1) and MHC (class I and II) molecules on pulmonary artery endothelial cells (HPAEC) incubated with various concentrations of rIL-1α. Bars show the mean ± s.d. of quadruplicate experiments.
Fig 2
Fig 2
(See next page) Expression of adhesion and MHC molecules on pulmonary artery endothelial cells (HPAEC) incubated with various concentrations of anti-U1-RNP+ (n = 19), anti-dsDNA+ (n = 19) and control (n = 10) IgGs. The addition of 200 μg/ml anti-U1-RNP+ and anti-dsDNA+ IgGs to HPAEC significantly up-regulated the expression of ICAM-1 (a, P < 0.001 and P < 0.01, respectively), ELAM-1 (b, P < 0.001 and P < 0.01, respectively), and class II MHC molecule (d, P < 0.05 and P < 0.05, respectively) compared with the levels expressed by HPAEC incubated with 200 μg/ml control IgG. Class I MHC molecule expression (c) on HPAEC was up-regulated neither by anti-U1-RNP+ nor anti-dsDNA+ IgGs.
Fig 3
Fig 3
Expression of adhesion and MHC molecules on pulmonary artery endothelial cells (HPAEC) incubated with various concentrations of purified anti-U1-RNP and anti-U1-RNP-depleted IgG. Purified anti-U1-RNP, but not anti-U1-RNP-deleted IgG, up-regulated ICAM-1 (a), ELAM-1 (b) and class II (d) MHC molecule expression on HPAEC in a concentration-dependent manner. Class I MHC molecule expression (c) on HPAEC was up-regulated neither by purified IgG anti-U1-RNP nor by anti-U1-RNP-depleted IgG. **P < 0.01; *P < 0.05 compared with adhesion and MHC molecule expression on HPAEC incubated with corresponding concentrations of anti-U1-RNP-depleted IgG.

References

    1. Asherson RA. Pulmonary hypertension in systemic lupus erythematosus. J Rheumatol. 1990;17:414–5. - PubMed
    1. Luchi ME, Asherson RA, Lahita RG. Primary idiopathic pulmonary hypertension complicated by pulmonary arterial thrombosis. Association with antiphospholipid antibodies. Arthritis Rheum. 1992;35:700–5. - PubMed
    1. Asherson RA, Higenbottam TW, Xuan ATD, Khamashta MA, Hughes GRV. Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol. 1990;17:1292–8. - PubMed
    1. Okawa-Takatsuji M, Aotsuka S, Uwatoko S, Sumiya M, Yokohari R. Enhanced synthesis of cytokines by peripheral blood monocytes cultured in the presence of autoantibodies against U1-ribonucleoprotein and/or negatively charged molecules: implication in the pathogenesis of pulmonary hypertension in mixed connective tissue disease (MCTD) Clin Exp Immunol. 1994;98:427–33. - PMC - PubMed
    1. Montefort S, Holgate ST. Adhesion molecules and their role in inflammation. Respir Med. 1991;85:91–99. - PubMed

MeSH terms